This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The over-the-counter supplement nicotinamide riboside, a form of vitamin B3, increased the walking endurance of patients with peripheralarterydisease, a chronic leg condition for which there are few effective treatments.
ObjectivesTo investigate the relationship between plasma aldosterone concentration (PAC) and the prevalence of peripheralarterydisease (PAD) in hypertensive patients and to determine any potential threshold effects.MethodsThis cross-sectional study analyzed data from 13,157 hypertensive individuals from the People's Hospital of Xinjiang Uygur Autonomous (..)
The study, called IVUS-DCB, is the first randomized controlled trial to demonstrate the clinical benefits of using IVUS in angioplasty procedures for peripheralarterydisease (PAD), a condition in which plaque builds up in arteries in the legs.
BackgroundFollowing the identification of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, research in this area has experienced significant growth. However, a thorough bibliometric analysis of this burgeoning field remains conspicuously absent.
Researchers at the Heart Research Institute (HRI) have made a new discovery, finding an existing drug used to kill tumor cells in cancer patients could also be used to save the limbs of patients with blocked arteries in their legs.
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
Further prospective clinical research is required to validate the relationship between the RDW/ALB ratio and PAD. Subgroup and PSM analyses underscored the consistency of these findings.ConclusionsThe study demonstrated a significant association between RDW/ALB and PAD, with a nonlinear relationship and a threshold effect.
18, 2024 — In November, Esperion presented an analysis from the CLEAR Outcomes study focused on patients with PeripheralArteryDisease (PAD) who were unable or unwilling to take statin medications. Bonaca, MD, MPH, FAHA, FACC, CPC Clinical Research. tim.hodson Tue, 12/03/2024 - 16:52 Nov.
The first patient to undergo the procedure as part of the Research Institute’s Performance III clinical trial is Roslyn “Sunny” Gomes of Glendale, Ariz., who has suffered from peripheralarterydisease for years. HonorHealth Research Institute is one of 30 sites worldwide to offer the device.
New study findings underscore gaps in clinical trial representation of women and Hispanics for peripheralarterydisease (PAD) and chronic limb-threatening ischemia (CLTI) research. All studies were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.
Type 2 diabetes (T2D) and peripheralarterydisease (PAD) are recognized as independent risk factors contributing to excess mortality. Contemporary observational studies exploring the associations of risk fact.
Myocardial infarction (MI), stroke, peripheralarterialdisease (PAD), heart failure (HF) and chronic kidney disease (CKD) are common cardiovascular renal diseases (CVRD) manifestations for type 2 diabetes.
Research Highlights: Adults in their 50s with peripheralarterydisease or PAD — are more likely than adults older than 80 to undergo leg amputation one to five years after an emergency surgery to restore blood flow to the lower limbs. This study.
However, the prevalent use of TAVR on a diverse patient profile with different risk factors, such as peripheralarterydisease, precluded the possibility of a transfemoral approach despite the improvement of valves and delivery systems technology.
The Society for Cardiovascular Angiography & Interventions (SCAI) kicks off its SCAI Scientific Sessions 2024 this week, May 2-4 in Long Beach, CA, bringing together more than 1,800 clinicians, scientists, researchers, and innovators in the field of interventional cardiology and endovascular medicine. Sinai Hospital (New York, NY).
Peripheralarterydisease (PAD) is an atherosclerotic condition that affects a growing number of individuals worldwide, with estimates exceeding 220 million. Circulation: Cardiovascular Quality and Outcomes, Ahead of Print.
Each year, the American Heart Association (AHA) gathers a Statistical Update, described as a major source for monitoring cardiovascular health, risk factors and disease in the United States and global population, and published annually in the AHA flagship journal Circulation. In addition, 115.9 million adults have prediabetes; 29.3
Future research should focus on long-term safety and identifying which patient subgroups benefit most from DCBA.Systematic Review Registration[link] PROSPERO [CRD42024591967]. However, the effects on ACM and amputation remain inconclusive.
Researchers have discovered that the smooth muscle cells that line the arteries of people with atherosclerosis can change into new cell types and develop traits similar to cancer that worsen the disease.
Chronic Limb-Threatening Ischemia (CLTI) represents the most advanced stage of PeripheralArteryDisease (PAD) and is associated with dire prognosis, characterized by a substantial risk of limb amputation and.
Further prospective research is merited to understand this vulnerable population. Compared with PAD‐only, PAD/MVD was associated with a higher risk for major amputation (odds ratio [OR], 1.30 [95% CI, 1.28–1.32]), 1.32]), minor amputation (OR, 2.15 [95% CI, 2.12–2.18]), 2.18]), major adverse cardiac events (OR, 1.04 [95% CI, 1.03–1.04]),
The potential preventive effect of fenofibrate on lower extremity amputation (LEA) and peripheralarterialdisease (PAD) in patients with type 2 diabetes (T2D) is not fully elucidated.
General population samples from the National Health Research Institutes were used as the control group to compare the methylation status. Blood samples were processed to isolate leukocytes, and DNA was extracted using the DNeasy blood kit.
"The roundtable provided a unique opportunity to identify knowledge gaps and discuss how IVUS can enhance our understanding and treatment of peripheralarterial and deep venous pathology." They also emphasized the need for further research and evidence to support the integration of IVUS into routine clinical practice.
Furthermore, due to increasing patient complexity of management secondary to comorbid conditions, such as cardiovascular disease, the management of peripheralarterydisease associated with DFUs has become increasingly difficult, and care delivery is often episodic and fragmented.
A study in the Journal of Vascular Surgery revealed that adding FFRCT assessments to patient workups prior to peripheralarterydisease surgeries has a massive impact on coronary arterydisease detection, treatments, and long-term outcomes.
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
Research shows that in recent years almost half of all adults in the United States have been living with heart disease, one of the most prominent forms of vascular disease. Vascular disease affects the body’s vast network of blood vessels, veins and arteries.
The analysis identified 305 original research papers reporting outcomes on atherectomy for endovascular treatment of occlusive or stenotic disease in native, infrainguinal, peripheralarteries through May 2024. among 42 observational studies (4,195 patients) and 72.7% across 10 RCTs),3 and DCB without atherectomy (67.6%
The Society for Cardiovascular Angiography and Interventions (SCAI) 2024 conference presented impactful research that challenged traditional practices, introduced groundbreaking technology, offered novel tools for improved procedural decision-making, addressed disparities in peripheralarterialdisease (PAD) treatment, and showcased a promising new (..)
Researchers analyzed more than 145 million records covering every adult patient admitted to hospital in England over a nine-year period to establish the risk of long-term health outcomes following a heart attack -- in the largest study of its kind.
Patients with prior CABG were more likely to be male and had higher rates of diabetes, peripheralarterydisease and atrial fibrillation compared with patients without prior CABG. Results The study included 1042 patients with a median age and follow-up of 82 years and 25 (range: 0–72) months, respectively.
Endovascular repair has been demonstrated as a surgical option for mycotic aneurysms in other vessels, such as the aorta, but further research and replication are needed to establish the utility of coiling in the setting of paraspinal mycotic aneurysms.⁵⁻⁷
7 Research has shown inflammation plays a significant role in the development of atherosclerosis and ASCVD,8-10 and even the formation of plaque.11 However, the development of atherosclerosis is now known to be much more complex, with a key role for immune cells and inflammation in conjunction with hyperlipidemia and elevated LDL levels.7
Thus, many of the recommendations around resistance exercise prescription have been formulated based on research in this population. But of course, many other groups of people perform resistance training — some of whom have cardiovascular diseases or are in other unique situations such as being pregnant.
Thus, many of the recommendations around resistance exercise prescription have been formulated based on research in this population. But of course, many other groups of people perform resistance training — some of whom have cardiovascular diseases or are in other unique situations such as being pregnant.
In order to improve the quality of life and prolong the lives of women with PVD, more research is needed to identify and address these disparities. Future Research Needs According to the statement, there is a need to prioritize research to help define differences in PVD between men and women.
BackgroundThe burden of peripheralarterydisease (PAD) is increasing in low‐ and middle‐income countries. Future research should focus on identifying the underlying risk factors for PAD in this setting. Journal of the American Heart Association, Ahead of Print.
The resources from CMHC include up-to-date research, breaking news, industry publications, and cutting-edge training through in-person conferences, on-demand digital courses, and live webinars.
tim.hodson Mon, 01/13/2025 - 16:24 A new studyreports persistent disparities in outcomes for people with peripheralarterydisease (PAD) and its more severe form, chronic limb-threatening ischemia (CLTI) in the United States. This research is a start in that direction.
Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels, such as coronary heart disease, cerebrovascular disease (e.g., stroke), peripheralarterialdisease, congenital heart anomalies, deep vein thrombosis, and pulmonary embolism.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content